ConductScience.org, home

Paper36978303

Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review.

Rychlíčková J and 3 others. Antibiotics (Basel), 2023. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review. Papers, record 36978303. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978303

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
5.37
iCite
Revised in PubMed
2023-03-31
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rychlíčková JJitkahttps://orcid.org/0000-0001-5764-5326
2Kubíčková VVendula
3Suk PPavelhttps://orcid.org/0000-0001-5292-2654
4Urbánek KKarelhttps://orcid.org/0000-0002-3461-1649

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CZECRIN (LM2018128)Ministry of Education, Youth and Sports Czech RepublicPubMed

Source PubMed

Download CSV of grants

References87

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125267662New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/25267662PubMed
228680633Therapeutic drug monitoring for colistin therapy in severe multi-resistant Acinetobacter intracerebral abscess: A single case study with high-dose colistin and review of literature.SAGE Open Med Case Rep2017https://conductscience.org/library/papers/28680633PubMed
316723551Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16723551PubMed
418606838Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18606838PubMed
516503447Polymyxins: old antibiotics are back.Lancet2006https://conductscience.org/library/papers/16503447PubMed
628893773Colistin Is Extensively Lost during Standard In Vitro Experimental Conditions.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28893773PubMed
725267660Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/25267660PubMed
835722356Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report.Ann Transl Med2022https://conductscience.org/library/papers/35722356PubMed
935028178An LC-MS/MS method for simultaneous analysis of the cystic fibrosis therapeutic drugs colistin, ivacaftor and ciprofloxacin.J Pharm Anal2021https://conductscience.org/library/papers/35028178PubMed
1031660388Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data.Open Forum Infect Dis2019https://conductscience.org/library/papers/31660388PubMed
1128011614Dosing guidance for intravenous colistin in critically-ill patients.Clin Infect Dis2017https://conductscience.org/library/papers/28011614PubMed
1227418577Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Clin Infect Dis2016https://conductscience.org/library/papers/27418577PubMed
1321555763Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21555763PubMed
1430151222Rapid, simple, and clinically applicable high-performance liquid chromatography method for clinical determination of plasma colistin concentrations.J Pharm Health Care Sci2018https://conductscience.org/library/papers/30151222PubMed
1528335481Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach.Int J Mol Sci2017https://conductscience.org/library/papers/28335481PubMed
1623147733Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23147733PubMed
1732052041Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints.Clin Infect Dis2020https://conductscience.org/library/papers/32052041PubMed
1825441071
High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate.
J Chromatogr A2014https://conductscience.org/library/papers/25441071PubMed
1926369974Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26369974PubMed
2021114395Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing.Pharmacotherapy2010https://conductscience.org/library/papers/21114395PubMed

See all 87 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42404768
Analysis of the efficacy and safety of intravenous injection combined with nebulized inhalation of polymyxin E sodium methanesulfonate in the treatment of carbapenem resistant gram-negative bacterial infections in the lungs.
Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42404768PubMed
42183845Synergistic strategies to rescue the last-resort antibiotic colistin.Arch Microbiol2026https://conductscience.org/library/papers/42183845PubMed
41884470Efficacy and Safety of Different Colistin Administration Routes for Nosocomial Pneumonia Caused by Carbapenem-Resistant Organisms: A Single Centre, Open Label, Prospective Cohort Study.Drug Des Devel Ther2026https://conductscience.org/library/papers/41884470PubMed
41636946Stability of Colistin Active Forms in Biological Matrices: Effect of Temperature and Time.Eur J Drug Metab Pharmacokinet2026https://conductscience.org/library/papers/41636946PubMed
41258612Aztreonam-Avibactam: A Review in the Treatment of Serious Bacterial Infections Caused by Aerobic Gram-Negative Organisms.Drugs2026https://conductscience.org/library/papers/41258612PubMed
40629991Liquid chromatography-tandem mass spectrometry methods for clinical quantitation of antibiotics.Bioanalysis2025https://conductscience.org/library/papers/40629991PubMed
40458932Therapeutic Drug Monitoring of Amikacin and Colistin in Patients with Multidrug-Resistant Gram-Negative Infections Using a Portable Plasmonic Biosensor.Anal Chem2025https://conductscience.org/library/papers/40458932PubMed
40426572One Health at Risk: Plasmid-Mediated Spread of mcr-1 Across Clinical, Agricultural, and Environmental Ecosystems.Antibiotics (Basel)2025https://conductscience.org/library/papers/40426572PubMed
40246790A Systematic Review of Pharmacokinetic Studies of Colistin and Polymyxin B in Adult Populations.Clin Pharmacokinet2025https://conductscience.org/library/papers/40246790PubMed
40216659Meropenem-Vaborbactam for Treatment of Carbapenem-Resistant Enterobacterales: A Narrative Review of Clinical Practice Evidence.Infect Dis Ther2025https://conductscience.org/library/papers/40216659PubMed
39941468Colistin Use for the Treatment of Multi-Drug-Resistant Gram-Negative Severe Infections in ICU Patients: A Single-Center Study.J Clin Med2025https://conductscience.org/library/papers/39941468PubMed
39858357Cinnamic Acid Compounds (p-Coumaric, Ferulic, and p-Methoxycinnamic Acid) as Effective Antibacterial Agents Against Colistin-Resistant Acinetobacter baumannii.Antibiotics (Basel)2025https://conductscience.org/library/papers/39858357PubMed
39502715A Rapid and Simple HPLC-MS/MS Method for the Quantitative Determination of Colistin for Therapeutic Drug Monitoring in Clinical Practice.Drug Des Devel Ther2024https://conductscience.org/library/papers/39502715PubMed
39378315Innovative Microencapsulation of Polymyxin B for Enhanced Antimicrobial Efficacy via Coated Spray Drying.Mol Pharm2025https://conductscience.org/library/papers/39378315PubMed
39335037Focusing on the Basic Principles of Dialysis to Optimize Antibiotic Therapy during Renal Replacement Therapy in Critically Ill Patients.Antibiotics (Basel)2024https://conductscience.org/library/papers/39335037PubMed
39257909
An overview of sulbactam-durlobactam approval and implications in advancing therapeutics for hospital-acquired and ventilator-associated pneumonia by acinetobacter baumannii-calcoaceticus complex: A narrative review.
Health Sci Rep2024https://conductscience.org/library/papers/39257909PubMed
39065030Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review.Microorganisms2024https://conductscience.org/library/papers/39065030PubMed
39050734Metabolomics highlights biochemical perturbations occurring in the kidney and liver of mice administered a human dose of colistin.Front Mol Biosci2024https://conductscience.org/library/papers/39050734PubMed
38931420Implementation of Modern Therapeutic Drug Monitoring and Lipidomics Approaches in Clinical Practice: A Case Study with Colistin Treatment.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38931420PubMed
38540175At the Intersection of Critical Care and Infectious Diseases: The Year in Review.Biomedicines2024https://conductscience.org/library/papers/38540175PubMed

See all 23 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
LDLR3949PubTator's text mininghttps://conductscience.org/library/genes/3949NCBI Gene
LRP24036PubTator's text mininghttps://conductscience.org/library/genes/4036NCBI Gene
SLC15A26565PubTator's text mininghttps://conductscience.org/library/genes/6565NCBI Gene
SLC22A46583PubTator's text mininghttps://conductscience.org/library/genes/6583NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36978303

GET https://conductscience.org/api/papers/v1/36978303/references?page=2